Amgen

company

About

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.

  • 10001 - max

Details

Industries
Biotechnology,Health Care,Manufacturing,Pharmaceutical
Founded date
Jan 1, 1980
Number Of Employee
10001 - max
Operating Status
Active

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases. The company is values-based and deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious diseases. They offer products for treating illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience.

Investments

Number of Investments
Number of Lead Investments
23
7
Amgen has made 23 investments. Their most recent investment was on Oct 11, 2022, when Neumora Therapeutics raised $112M.
Date Company Name
Round Money Raised Industry Lead Investor
Series B $112M Biotechnology
Sep 19, 2022 Motion
Series A $13M Analytics
May 25, 2022 Meter
Series B $38M Information Technology
May 12, 2022 TipTop
Series A $23M Cryptocurrency
Apr 14, 2022 Context
Seed $19.50M Apps Yes

Acquisition

Amgen has acquired 1 organizations. Their most recent acquisition was Horizon Pharma on Dec 12, 2022. They acquired Horizon Pharma for $27.80B.

Date Company Name
Industry Acquisition Type Price
Dec 12, 2022 Horizon Pharma
Biopharma acquisition $ 27.80B Detail